According to these results, it has been previously shown that the transfer of low dose of CD4+ T-cells (5 × 104 cells per mouse) exerts a stronger effect than higher doses of CD4+ T-cells in an anti-tumour therapy (47). This evidence concerns the gene CD4 and neoplasm.